Yeowon Sohn
Overview
Explore the profile of Yeowon Sohn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Nam Y, Jeon D, Choi Y, Choi S, Hong C, et al.
Exp Mol Med
. 2025 Mar;
PMID: 40087529
Hypoimmunogenic universal induced pluripotent stemn (iPS) cells were generated through the targeted disruption of key genes, including human leukocyte antigen (HLA)-A, HLA-B and HLA-DR alpha (DRA), using the CRISPR-Cas9 system....
2.
Song S, Nam Y, Rim Y, Ju J, Sohn Y
Stem Cell Res Ther
. 2024 Nov;
15(1):447.
PMID: 39574212
Stem cell therapies have emerged as a promising approach in regenerative medicine, demonstrating potential in personalized medicine, disease modeling, and drug discovery. Therapies based on induced pluripotent stem cells (iPSCs)...
3.
Sunwoong P, Rim Y, Sohn Y, Nam Y, Ju J
Cell Transplant
. 2024 Oct;
33:9636897241283539.
PMID: 39437338
With the aging population, the incidence of degenerative diseases such as dementia and arthritis is on the rise. To combat these diseases, cell therapies using induced pluripotent stem cells (iPSCs)...
4.
Park J, Rim Y, Sohn Y, Nam Y, Ju J
Histol Histopathol
. 2024 Jun;
40(2):157-170.
PMID: 38847077
The World Health Organization has identified Alzheimer's disease (AD), the leading cause of dementia globally, as a public health priority. However, the complex multifactorial pathology of AD means that its...
5.
Ju H, Sohn Y, Nam Y, Rim Y
Stem Cell Res Ther
. 2024 May;
15(1):142.
PMID: 38750578
Researchers have attempted to generate transfusable oxygen carriers to mitigate RBC supply shortages. In vitro generation of RBCs using stem cells such as hematopoietic stem and progenitor cells (HSPCs), embryonic...
6.
Park G, Rim Y, Sohn Y, Nam Y, Ju J
Stem Cell Rev Rep
. 2024 Apr;
20(6):1375-1386.
PMID: 38639829
Various groups including animal protection organizations, medical organizations, research centers, and even federal agencies such as the U.S. Food and Drug Administration, are working to minimize animal use in scientific...
7.
Elmgren L, Li X, Wilson C, Ball R, Wang J, Cichutek K, et al.
Vaccine
. 2013 Apr;
31 Suppl 2:B163-75.
PMID: 23598478
The Decade of Vaccines Collaboration and development of the Global Vaccine Action Plan provides a catalyst and unique opportunity for regulators worldwide to develop and propose a global regulatory science...
8.
Griffiths E, Thorpe R, Wadhwa M, Sohn Y
Biologicals
. 2011 Sep;
39(5):249.
PMID: 21925898
No abstract available.
9.
Han Y, Jin B, Lee S, Sohn Y, Joung J, Lee J
Arch Pharm Res
. 2007 Oct;
30(9):1124-31.
PMID: 17958330
Few researches on the protein stabilization of recombinant human serum albumin (rHSA) have been done. In the present study, we assessed the impact of sugar lyoprotectants on the protein stability...
10.
Ahn S, Jeong S, Kim Y, Sohn Y, Moon A
Cancer Lett
. 2004 Mar;
207(1):49-57.
PMID: 15050733
The matrix metalloproteases (MMPs) play important roles in invasion, metastasis and angiogenesis in various cell types. Tissue inhibitor of metalloprotease (TIMP)-2, an endogenous inhibitor of MMP-2, has been shown to...